Document Type

Article

Language

eng

Format of Original

13 p.

Publication Date

8-2013

Publisher

Optical Society of America

Source Publication

Biomedical Optics Express

Source ISSN

2156-7085

Original Item ID

doi: 10.1364/BOE.4.001305; PubMed Central: PMCID 3756583

Abstract

The adaptive optics scanning light ophthalmoscope (AOSLO) allows visualization of microscopic structures of the human retina in vivo. In this work, we demonstrate its application in combination with oral and intravenous (IV) fluorescein angiography (FA) to the in vivo visualization of the human retinal microvasculature. Ten healthy subjects ages 20 to 38 years were imaged using oral (7 and/or 20 mg/kg) and/or IV (500 mg) fluorescein. In agreement with current literature, there were no adverse effects among the patients receiving oral fluorescein while one patient receiving IV fluorescein experienced some nausea and heaving. We determined that all retinal capillary beds can be imaged using clinically accepted fluorescein dosages and safe light levels according to the ANSI Z136.1-2000 maximum permissible exposure. As expected, the 20 mg/kg oral dose showed higher image intensity for a longer period of time than did the 7 mg/kg oral and the 500 mg IV doses. The increased resolution of AOSLO FA, compared to conventional FA, offers great opportunity for studying physiological and pathological vascular processes.

Comments

Accepted version. Biomedical Optics Express, Vol. 4, No. 8 (August 2013): 1305-1317. DOI. © Optical Society of America 2013. Used with permission.

Share

COinS